Stabilized Platelets for Advanced Wound Healing

Information

  • Research Project
  • 6833207
  • ApplicationId
    6833207
  • Core Project Number
    R43DK068932
  • Full Project Number
    1R43DK068932-01
  • Serial Number
    68932
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/2004 - 21 years ago
  • Project End Date
    4/30/2005 - 20 years ago
  • Program Officer Name
    BISHOP, TERRY ROGERS
  • Budget Start Date
    8/1/2004 - 21 years ago
  • Budget End Date
    4/30/2005 - 20 years ago
  • Fiscal Year
    2004
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/23/2004 - 21 years ago
Organizations

Stabilized Platelets for Advanced Wound Healing

[unreadable] DESCRIPTION (provided by applicant): [unreadable] The overall goal of this Phase I proposal is to determine the resiliency of platelets during the stabilization process to co-accumulate secondary compounds to enhance their wound healing attributes. This work is based on the extensive documentation of pooled secretion of growth factors from platelets for healing properties and the licensing of stabilization technology for freeze-drying trehalose-loaded platelets that results in 90% recovery following rehydration with normal response to physiological agonists. By exploiting these natural properties of dry stabilized platelets with enhanced product delivery attributes and their incorporation in wound matrices and materials (hydrogels, wound bandage materials), we intend to create a dramatically improved wound healing product for the patients suffering from chronic, ulceric wounds. A range of secondary compounds, from peptides to inert polymers, and loading methodologies, from endocytotic to peptide-mediated, will be evaluated for their applicability for pre-freeze drying loading. Phase II of the project will advance the most promising loading methodologies with the leading Ioadable secondary wound healing compounds for subsequent characterization in wound bandage materials by in vitro and in vivo animal wound healing models. [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R43
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99076
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:99076\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ADLYFE, INC.
  • Organization Department
  • Organization DUNS
    137192840
  • Organization City
    ROCKVILLE
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20850
  • Organization District
    UNITED STATES